D.A. Davidson & CO. Increases Stock Holdings in Doximity, Inc. $DOCS

D.A. Davidson & CO. raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 25.5% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 27,066 shares of the company’s stock after acquiring an additional 5,492 shares during the quarter. D.A. Davidson & CO.’s holdings in Doximity were worth $1,660,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. VSM Wealth Advisory LLC purchased a new position in shares of Doximity during the 1st quarter worth $29,000. Allworth Financial LP boosted its stake in shares of Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock worth $32,000 after acquiring an additional 287 shares during the last quarter. National Bank of Canada FI purchased a new position in shares of Doximity during the 1st quarter worth $33,000. Spire Wealth Management boosted its stake in shares of Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after acquiring an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group boosted its stake in shares of Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after acquiring an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Performance

NASDAQ:DOCS opened at $66.93 on Monday. The stock’s fifty day moving average is $69.60 and its 200 day moving average is $61.85. Doximity, Inc. has a fifty-two week low of $40.87 and a fifty-two week high of $85.21. The firm has a market capitalization of $12.54 billion, a PE ratio of 66.93, a PEG ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the previous year, the company posted $0.28 earnings per share. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DOCS. Wells Fargo & Company boosted their price objective on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research note on Monday, August 4th. The Goldman Sachs Group set a $64.00 price objective on shares of Doximity and gave the stock a “sell” rating in a research note on Wednesday, October 1st. Evercore ISI increased their price objective on shares of Doximity from $75.00 to $81.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Raymond James Financial set a $75.00 price objective on shares of Doximity in a research note on Wednesday, September 10th. Finally, Canaccord Genuity Group increased their price objective on shares of Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a research note on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $69.37.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $2,635,880 in the last ninety days. 31.30% of the stock is owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.